Founder & Managing Partner
In 2026, he founded Kynos Advisory.
Jan Meurer began his career at Procter & Gamble in 1998 in brand management in Germany, then at the company’s European headquarters in Switzerland. At the company’s world headquarters in the US, as Global Brand Director for Always/Whisper, he led development of Always Infinity, a first-of-its-kind foam technology that later won the Edison Innovation Gold Award. P&L roles followed across Latin America and Western Europe: in Latin America, Feminine Care turnover grew 19% a year and profit doubled in two years; in Western Europe, a declining €200 million consumer health business was reversed to 27% profit CAGR across 17 markets. In Eastern Europe, he ran a $1.5 billion Beauty & Grooming division across Russia and Ukraine to a value share above 50%, then, as Managing Director, led the P&G/Teva joint venture through the Crimea conflict, delivering a 20% CAGR without disruption to the business.
He joined Johnson & Johnson in 2015 to run the company’s largest EMEA Consumer Health cluster, and in 2019 became President of J&J Southeast Asia — the only region in J&J’s history to operate Consumer, Pharmaceuticals and Medical Devices under a single P&L. Expanding beyond consumer goods into pharmaceuticals and medical devices, he distilled more than 400 segment-country combinations into one investment framework, delivering record profit, free cash flow and growth across all three sectors.
In 2022 he was appointed Chief Growth Officer and Global Head of Strategy — a seat on Kenvue’s Executive Committee with line authority over the company’s three global franchise presidents, its strategy function, M&A and ESG, the broadest mandate below the CEO. Tasked with separating J&J’s Consumer Health business and taking it public, he architected the $4.4 billion Kenvue IPO — the largest US corporate carve-out in over twenty years — leading the S-1, the investor roadshow, analyst and rating-agency presentations. He also built the company itself: its name, purpose and values, corporate identity, organizational structure, 5-year strategy and new global headquarters.
He returned to operations in 2024 as Group President of Kenvue North America, a $7.5 billion P&L, roughly half the company’s global revenue. He arrested a multi-year share decline, returned the Neutrogena Face franchise to the #1 value and volume position, and delivered eight consecutive quarters of share growth in Self Care. Q4 2025 and Q1 2026 both beat Wall Street’s expectations. Following Kimberly-Clark’s acquisition of Kenvue, announced in November 2025, he led a structured leadership transition through mid-2026.
In 2026, he founded Kynos Advisory.
Leadership roles at global consumer companies, across markets and business cycles.
Led the $7.5 billion reset of the largest region.
Member of the Executive Committee. Architected the $4.4 billion IPO, the largest US corporate carve-out in over twenty years.
Senior leadership roles across global markets.
Multiple operating roles across brands and regions.
I take on a select number of mandates at a time, so I can be genuinely close to the work, rather than advising from a distance. I’ve sat in the operating chair — on the P&L, in the boardroom, with analysts and investors — and I bring that same directness to my advisory work: judgment that’s been tested, not just offered.
Diplom-Kaufmann (MBA equivalent), University of Passau, Germany. Rotary Foundation Scholar, USA.
English, German, Spanish, French.
Diplom-Kaufmann (MBA equivalent), University of Passau, Germany.
Rotary Foundation Scholar, USA.
English, German, Spanish, French.
My grandfather captained ships from the North Sea down the Rhine. Navigation has always run in the family — his, on the water; mine, leading businesses across four continents.
Twenty-eight years taught me that the leaders who win are rarely the ones with the most data. They’re the ones who can find, in conditions built to disorient, the signal that actually matters. That’s what Kynos brings to my partners: the clarity to make hard calls with conviction, even when the situation is anything but clear.
Kynos Advisory takes on a select number of mandates at a time.